Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.
<h4>Background</h4>Huntington's disease (HD) is an inherited, progressive neurodegenerative disease that has no cure. Striatal atrophy and hypometabolism has been described in HD as far as 15 years before clinical onset and therefore structural and functional imaging biomarkers are...
Guardado en:
Autores principales: | Marie N N Hellem, Tua Vinther-Jensen, Lasse Anderberg, Esben Budtz-Jørgensen, Lena E Hjermind, Vibeke Andrée Larsen, Jørgen E Nielsen, Ian Law |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92c324f278e24176875b8adc52bf1c98 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The relationship between non-motor features and weight-loss in the premanifest stage of Huntington's disease.
por: Wasiq Khan, et al.
Publicado: (2021) -
Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Travis Cruickshank, et al.
Publicado: (2021) -
FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils
por: Jonathan D. West MD, et al.
Publicado: (2021) -
FDG-PET/CT in predicting aggressiveness of rectal cancer
por: Iman Sherif Ahmed, et al.
Publicado: (2021) -
UTILIDAD DEL PET-FDG EN PATOLOGÍA NEUROPEDIATRICA
por: Massardo V,Teresa, et al.
Publicado: (2007)